Gene · 2071
Papers2,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| R-loop induced G-quadruplex in non-template promotes transcription by successive R-loop formation. | Nat Commun | 2020 | 32636376 | PubTator, text mining | PubMed |
| Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE Trial. | Cancers (Basel) | 2020 | 32629861 | PubTator, text mining | PubMed |
| Overcoming cancer therapeutic bottleneck by drug repurposing. | Signal Transduct Target Ther | 2020 | 32616710 | PubTator, text mining | PubMed |
| A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone. | J Immunother Cancer | 2020 | 32616555 | PubTator, text mining | PubMed |
| DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome. | Cancers (Basel) | 2020 | 32605254 | PubTator, text mining | PubMed |
| Moonlighting in Mitosis: Analysis of the Mitotic Functions of Transcription and Splicing Factors. | Cells | 2020 | 32604778 | PubTator, text mining | PubMed |
| Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2020 | 32599951 | PubTator, text mining | PubMed |
| Applications of single-cell sequencing for the field of otolaryngology: A contemporary review. | Laryngoscope Investig Otolaryngol | 2020 | 32596483 | PubTator, text mining | PubMed |
| Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer. | Cancers (Basel) | 2020 | 32560564 | PubTator, text mining | PubMed |
| Early-onset nucleotide excision repair disorders with neurological impairment: Clues for early diagnosis and prognostic counseling. | Clin Genet | 2020 | 32557569 | PubTator, text mining | PubMed |
| Emerging Roles of Post-Translational Modifications in Nucleotide Excision Repair. | Cells | 2020 | 32549338 | PubTator, text mining | PubMed |
| Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding. | Cancers (Basel) | 2020 | 32545553 | PubTator, text mining | PubMed |
| Disruption of TFIIH activities generates a stress gene expression response and reveals possible new targets against cancer. | Open Biol | 2020 | 32543350 | PubTator, text mining | PubMed |
| 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes. | Cancer Sci | 2020 | 32536012 | PubTator, text mining | PubMed |
| Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer. | Int J Mol Sci | 2020 | 32517194 | PubTator, text mining | PubMed |
| An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer. | Cancers (Basel) | 2020 | 32512900 | PubTator, text mining | PubMed |
| The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles. | Cancers (Basel) | 2020 | 32512867 | PubTator, text mining | PubMed |
| Elucidating the role of excision repair cross-complement group 1 in oral epithelial dysplasia and early invasive squamous cell carcinoma: An immunohistochemical study. | J Oral Maxillofac Pathol | 2020 | 32508443 | PubTator, text mining | PubMed |
| Conditional reprogramming: Modeling urological cancer and translation to clinics. | Clin Transl Med | 2020 | 32508060 | PubTator, text mining | PubMed |
| The sunless tanning agent dihydroxyacetone induces stress response gene expression and signaling in cultured human keratinocytes and reconstructed epidermis. | Redox Biol | 2020 | 32506039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2071/papers?page=40